Increased susceptibility to allergic and autoimmune diseases in patients with activated phosphoinositide 3-kinase (PI3K) delta syndrome (APDS)

被引：0
|
作者：
Kubala, Stephanie [1 ]
Rasooly, Marjohn [1 ]
Uzel, Gulbu [2 ]
Frischmeyer-Guerrerio, Pamela [1 ]
机构：
[1] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] NIAID, Lab Clin Immunol & Microbiol, 9000 Rockville Pike, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2021年 / 41卷 / SUPPL 1期
关键词：
PI3K; PIK3CD; APDS; allergy; autoimmunity;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
65
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [1] ACTIVATED PHOSPHOINOSITIDE 3-KINASE (PI3K) DELTA SYNDROME (APDS) MAY HIDE BEHIND EVOLVING MANIFESTATIONS IN EARLY CHILDHOOD
    Kubala, S.
    Uzel, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S103 - S103
  • [2] Overall survival among patients with activated phosphoinositide 3-kinase delta syndrome (APDS)
    Malena Mahendran
    Julia E. M. Upton
    Ramya Ramasubramanian
    Heidi L. Memmott
    Guillaume Germain
    Katharina Büsch
    François Laliberté
    Amanda Harrington
    Orphanet Journal of Rare Diseases, 20 (1)
  • [3] Infections in activated PI3K delta syndrome (APDS)
    Brodsky, Nina N.
    Lucas, Carrie L.
    CURRENT OPINION IN IMMUNOLOGY, 2021, 72 : 178 - 189
  • [4] INTUSSCEPTION: A NOVEL PRESENTATION OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE-Δ (PI3KΔ) SYNDROME (APDS)
    Gold, M.
    Chan, D.
    Marchand, B.
    Dzeladini, L.
    King, J.
    Cheung, A.
    Quinn, P.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 29
  • [5] The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS)
    Fekrvand, Saba
    Delavari, Samaneh
    Chavoshzadeh, Zahra
    Sherkat, Roya
    Mahdaviani, Seyed Alireza
    Shabestari, Mahnaz Sadeghi
    Azizi, Gholamreza
    Arzanian, Mohammad Taghi
    Shamsian, Bibi Shahin
    Eskandarzadeh, Shabnam
    Eslami, Narges
    Rae, William
    Condino-Neto, Antonio
    Mohammadi, Javad
    Abolhassani, Hassan
    Yazdani, Reza
    Aghamohammadi, Asghar
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (03) : 644 - 659
  • [6] OVERALL SURVIVAL (OS) AMONG PATIENTS WITH ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS)
    Harrington, A.
    Mahendran, M.
    Ramasubramanian, R.
    Memmott, H.
    Germain, G.
    Busch, K.
    Laliberte, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S63 - S64
  • [7] Activated Phosphoinositide 3-Kinase Syndrome (APDS): a Diagnosis to be Aware of
    Barp, M. F.
    Silva, P. A.
    Silva, P. F.
    Dorna, M. B.
    Castro, A. P. B. M.
    Santos, C. J. N.
    Pastorino, A. C.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S34 - S34
  • [8] Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function
    Fung-Leung, Wai-Ping
    CELLULAR SIGNALLING, 2011, 23 (04) : 603 - 608
  • [9] Activated PI3K Delta Syndrome (APDS) in Two Peruvian Pediatric Patients
    Toribio-Dionicio, Crhistian
    Cubas-Guzman, Dania
    Cordova-Calderon, Wilmer
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S68 - S69
  • [10] MORTALITY IN PATIENTS WITH ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS), A SYSTEMATIC LITERATURE REVIEW (SLR)
    Busch, K.
    Memmott, H.
    McLaughlin, H.
    Harrington, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S63 - S63
12345